In addition to autoimmune diseases, accumulating evidence demonstrates that NFAT5 is associated with the progression of various types of tumors, including breast cancer, hepatocellular carcinoma, and lung cancer (69–71). This evidence concerns the gene NFAT5 and hepatocellular carcinoma.